Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Web Exclusives
Press Releases
AVBCC Highlights
Oncology and Vertically Integrated Supply Channels
AVBCC 2023 Summit
AVBCC Highlights
— November 27, 2023
Supply channels are becoming more and more complex, and their models are evolving with an abundance of services to support both the providers and suppliers. Such complexity is causing both challenges and opportunities in this arena. What does the future hold?
Read Article
Evolution of Clinical Trials
AVBCC 2023 Summit
AVBCC Highlights
— November 27, 2023
Clinical trials have evolved over the years from gated phase 1, 2, and 3 approaches to more blended phase options and single-arm trials. However, we’re still seeing many of the same challenges, such as lack of patient access and diversity, similar or rising cost, and increasing complexity. Our panel of experts discussed the evolution of clinical trials and some unique solutions being considered for the future.
Read Article
A View on Legislation and Policy Out of Washington Ahead
AVBCC 2023 Summit
AVBCC Highlights
— November 27, 2023
From the Pharmacy Benefits Manager (PBM) Reform Act and 340B Drug Pricing Program to drug shortages and the Inflation Reduction Act, this panel of Washington healthcare experts separated fact from fiction and noise from reality to provide a clear understanding for current legislative priorities.
Read Article
Cancer Research and the Road Ahead
AVBCC 2023 Summit
AVBCC Highlights
— November 27, 2023
Cancer treatments are advancing rapidly, thanks to the diligence of researchers and the foundations that support them. Panelists discussed emerging therapies, the impact of funding organizations, and what the future holds for the fight against cancers.
Read Article
AI and ML Decision Support Models
AVBCC 2023 Summit
AVBCC Highlights
— November 27, 2023
Artificial intelligence (AI) and machine learning (ML) platforms are becoming essential to the value equation in healthcare and to managing the complexity and range of treatment options within cancer care today. Panelists in this session explored the application of AI and ML technologies and their impact on care, outcomes, cost, providers, pharma, payers, and patients as well as their integrations between electronic medical records and future systems.
Read Article
New Patient-Centric Cancer Care Models
AVBCC
AVBCC Highlights
— December 21, 2022
The traditional role of oncology physicians as providers who diagnose disease and provide treatment has evolved as healthcare has shifted from a purely clinical discipline to one where patient-centered care is the focus.
Read Article
The Evolving Role of Social Determinants of Health in Value-Based Care
AVBCC
AVBCC Highlights
— December 21, 2022
Although
The Unequal Burden of Cancer: An Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved
was published in 1999 and Z-codes were added to the International Classification of Diseases codes in 2015, social determinants of health were barely considered prior to the COVID-19 pandemic.
Read Article
Disparities and the Impact on Cancer Care
AVBCC
AVBCC Highlights
— December 21, 2022
Moderator Sybil Green, JD, RPh, MHA, of the American Society of Clinical Oncology, admitted at the start of a panel discussion exploring “Disparities and the Impact on Cancer Care” at the 2022 AVBCC annual conference in New York City that this was not a novel topic.
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma